Table 1.
Minimum inhibitory concentrations
| Bacteria | Antibiotic or AgNPs | MIC ± SD (µg/mL) |
|---|---|---|
| Stenotrophomonas maltophilia HCR-392861G− | AgNPs | 4.66 ± 1.15 |
| Ceftazidime | 74.66 ± 18.47 | |
| Escherichia coli ATCC 25922G− | AgNPs | 4.00 ± 0.0 |
| Ceftazidime | 0.25 ± 0.0 | |
| Staphylococcus aureus INR-16-1700G+ | AgNPs | 6.00 ± 2.00 |
| Oxacillin | 128.00 ± 0.0 | |
| Enterococcus faecalis ATCC 29212G+ | AgNPs | 7.30 ± 1.15 |
| Oxacillin | 9.30 ± 2.30 |
Table shows minimum inhibitory concentrations of silver nanoparticles in solution and of antibiotics against clinical bacteria strains, HCR-392861 and INR-16-1700, and against reference bacteria strains ATCC 25922 and ATCC 29212
AgNPs silver nanoparticles, MIC minimum inhibitory concentration, SD standard deviation, G+ Gram-positive bacteria and G− Gram-negative bacteria